AMGN
Amgen Inc
NASDAQ: AMGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$346.25
+2.43% today
Updated 2026-04-29
Market cap
$185.74B
P/E ratio
24.21
P/S ratio
5.05x
EPS (TTM)
$14.23
Dividend yield
2.73%
52W range
$253 – $391
Volume
2.6M
WallStSmart proprietary scores
70
out of 100
Grade: B
Buy
Investment rating
8.0
Growth
A5.0
Quality
C+8.5
Profitability
A4.7
Valuation
C4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$352.73
+1.87%
12-Month target
$352.30
+1.75%
Intrinsic (DCF)
$318.30
Margin of safety
-6.20%
4 Strong Buy9 Buy18 Hold2 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 21.00% — above average
+ ROE 106.10% — strong efficiency
+ Free cash flow $961.00M — positive
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $26.32B | $28.19B | $33.42B | $36.74B | $36.75B | $38.6B |
| Net income | $6.55B | $6.72B | $4.09B | $7.71B | $1.33B | — |
| EPS | — | — | — | — | $14.23 | $22.82 |
| Free cash flow | $8.79B | $7.36B | $10.39B | $8.10B | $961.00M | — |
| Profit margin | 24.89% | 23.83% | 12.24% | 20.99% | 21.00% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-16 | SANTOS, ESTEBAN | Sale | 5,621 | $366.21 |
| 2026-03-16 | REESE, DAVID M | Sale | 6,022 | $366.21 |
| 2026-03-16 | MILLER, DEREK | Sale | 1,616 | $366.21 |
Peer comparison
Smart narrative
Amgen Inc trades at $346.25. representing a P/E of 24.21x trailing earnings. Our Smart Value Score of 70/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $36.75B. with profit margins at 21.00%. Our DCF model estimates intrinsic value at $318.30.
Frequently asked questions
What is Amgen Inc's stock price?
Amgen Inc (AMGN) trades at $346.25.
Is Amgen Inc overvalued?
Smart Value Score 70/100 (Grade B, Buy). DCF value $318.30.
What is the price target of Amgen Inc (AMGN)?
The analyst target price is $352.73, representing +1.9% upside from the current price of $346.25.
What is the intrinsic value of Amgen Inc (AMGN)?
Based on our DCF model, intrinsic value is $318.30, a -6.2% margin of safety versus $346.25.
What is the future stock price of AMGN by 2030?
Our research-backed model estimates Amgen Inc could reach $514.85 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Amgen Inc's revenue?
TTM revenue is $36.75B.
Piotroski F-Score?
4/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.05x
ROE106.10%
Beta0.47
50D MA$361.11
200D MA$323.82
Shares out0.54B
Float0.54B
Short ratio—
Avg volume2.6M
Performance
1 week-1.90%
1 month-4.32%
3 months-1.13%
YTD+3.27%
1 year—
3 years—
5 years—